Search Results 211-220 of 17779 for cbd

  1. A Study to Investigate the Effectiveness and Safety of ZX008 in Subjects with CDKL5 Deficiency Disorder - Mayo Clinic

    - Subject is receiving concomitant treatment with cannabidiol (CBD) other than Epidiolex/Epidyolex or is being actively treated with tetrahydrocannabinol ...

  2. A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome - Mayo Clinic

    Subject has a positive result on urine THC Panel or whole blood CBD at the Screening Visit. Subject has a clinically significant condition, or has had ...

  3. A Study To Investigate The Effectiveness And Safety Of Fenfluramine Hydrochloride As An Adjunctive Therapy In Children And Adults With Lennox-Gastaut Syndrome - Mayo Clinic

    Subject has positive result (as defined in the laboratory manual) on urine or serum tetrahydrocannabinol (THC) Panel or whole blood cannabidiol (CBD) at the ...

  4. A Study To Evaluate The Safety, Pharmacokinetics, And Anti-tumor Activity Of LYT-200 Alone And Combined With Chemotherapy Or Tislelizumab To Treat Patients With Metastatic Solid Tumors - Mayo Clinic

    Prior or current illicit drug addiction (medical and recreational marijuana/cannabidiol [CBD]/ tetrahydrocannabinol [THC] would not be considered "illicit").

  5. Cannabis Allergy Study - Mayo Clinic

    About this study. The purpose of this study is to evaluate a serum IgE hemp antibody immunoassay for use in the evaluation of allergies to cannabis and ...

  6. A Study to Evaluate Variations in Episcleral Venous Pressure - Mayo Clinic

    Use of any products of cannabis (THC or CBD compounds) within the past 30 days. Lack of suitable episcleral vein for EVP measurement. Subjects who are not ...

  7. A Study To Investigate The Effectiveness And Safety Of Cannabidiol In Children And Young Adults With Dravet Syndrome - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. A Study To Evaluate The Effect Of Olorinab On Gastrointestinal Transit In Patients With Irritable Bowel Syndrome - Mayo Clinic

    Medical or recreational marijuana, tetrahydrocannabinol (THC), cannabidiol (CBD), synthetic cannabinoids, or other cannabis derivatives for any indication; ...

  9. Consumer health - Mayo Clinic

    CBD: Safe and effective? Colloidal silver supplements: Are they safe? Colon cleansing: Is it helpful or harmful? Detox foot pads: Do they really work ...

  10. Cannabinoid with Irritable Bowel Syndrome - Mayo Clinic

    About this study. The purpose of this study is to evaluate the effectiveness of cannabis in reducing pain, discomfort, and nausea associated with irritable ...